Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Verhaak PFM, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: A review of the literature. Pain, 1998, 77:231–239.
Glajchen M, Fitzmartin RD, Blum D, et al. Psychosocial barriers to cancer pain relief. Cancer Practice, 1995, 3(2):76–82.
Ramer L, Richardson JL, Cohen MZ, et al. Multimeasure pain assessment in an ethnically diverse group of patients with cancer. Journal of Transcultural Nursing, 1999, 10(2):94–101.
Ward SE, Goldberg N, Miller-McCoulry V, et al. Patient-related barriers to management of cancer pain. Pain, 1993, 52:319–324.
Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce. JAMA, 2003, 290:2443–2454.41.
Oaklander, A., The pathology of pain. Neuroscientist, 1999, 5(5):302–310.
Morgan JP. American opiophobia: customary underutilization of opioid analgesics. Advances in Alcohol & Substance Abuse, 1985, 5:163–73.
Pohl M. Pain. In Special Populations. 3rd ed. Principles of Addiction Medicine, Graham A et al, editors,Chevy Chase MD, American Society of Addiction Medicine, 2003.
Glajchen, M, Chronic pain: treatment barriers and strategies for clinical practice. Journal of American Board of Family Practice, 2001, 14(3):211–8.
Wise, R.A., Addiction becomes a brain disease. Neuron, 2000, 26(1): p. 27–33.
Acute Pain Management Guideline Panel. Acute Pain Management: Operative or Medical Procedures and Trauma; Clinical Practice Guideline. AHCPR Publication Number 92-0032, Rockville MD, Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1992.
Jacox A, Carr DB, Payne R, et al. Management of Cancer Pain. Clinical Practice Guideline. AHCPR Publication Number 94-0592, Rockville MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1994.
Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemicallydependent patients in methadone maintenance and residential treatment facilities. JAMA, 2003, 289(18):2370–8.
Savage SR. Long-term opioid therapy: assessment of consequences and risks. Journal of Pain and Symptom Management, 1996, 11(5):274–86.
Wassan AD, Correll DJ, Kissin I, O’Shea S, Jamison RN. Iatrogengenic addiction inpatients treated for acute or subacute pain. Journal of Opioid Management, 2006, 2(1): Jan./Feb.:16–21
Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Advances in Therapy, 2000, 17(2):70–83.
Compton, P. and G. Gebhart, The Neurophysiology of Pain and Interfaces with Addiction, in Principles of Addiction Medicine, A. Graham, et al., Editors. 2003, American Society of Addiction Medicine: Chevy Chase, MD. pp. 1385–1404.
Hoffman NG, Chang AJ, Lewis DC. Medical student attitudes toward drug addiction policy. Journal of Addictive Diseases, 2000, 19(3):1–12.
Heit HA. Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. Journal of Pain & Palliative Care Pharmacotherapy, 2003, 17(1):15–29.
Battin MP, Luna E, Lipman AG et al. Drugs and Justice: Seeking a Consistent, Coherent, Comprehensive View. NY, Oxford University Press, 2007.
Heit HA, Gourlay D. Chronic Pain and Addiction. In Chronic Abdominal and Visceral Pain: Theory and Practice. Pasricha PJ, Willis WD, Gebhart GF, editors, NY. Taylor and Francis, 2006.
Gourlay D, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Medicine, 2005, 6(2):107–12.
American Academy of Pain Medicine, American Pain Society, and American Society of Addiction Medicine. Definitions Related to the Use of Opioids for the Treatment of Pain, Glenview, IL, American Academy of Pain Medicine, 2001.
SR Savage, DE Joranson, EC Covington, SH Schnoll, HA Heit, AM Gilson. Definitions Related to the Medical Use of Opioids: Evolution Towards Universal Agreement. Journal of Pain and Symptom Management, 2003, 26(1):655–67.
Weissman DE, Haddox JD. Opioid pseudoaddiction – an iatrogenic syndrome. Pain, 1989, 36(3):363–6.
Pappagallo M., The concept of pseudotolerance to opioids. Journal of Pharmaceutical Care in Pain and Symptom Control, 1998, 6:95–8.
Lipman AG, Jackson KC. Opioids. In Warfield C, Bajwa Z, editors, Principles and Practice of Pain Management, 2nd edition, New York, McGraw Hill, 2003.
Fakata KL, Lipman AG. Opioid Bowel Dysfunction in Acute and Chronic Non-malignant Pain. In Yuan S-H, editor, Opioid Bowel Dysfunction, Binghamton NY, Haworth Medical Press, 2004.
Diagnostic and Statistical Manual of Mental Disorders – Text Revised, 4th edition, Washington DC, American Psychiatric Association, 2000.
Heit HA, Gourlay D. Urine drug testing in pain medicine. Journal of Pain and Symptom Management, 2004, 27(3):260–7.
Gourlay D, Heit HA, Caplan YH. Urine Drug Testing in Primary Care: Dispelling the Myths & Designing Strategies. San Francisco, California Academy of Family Physicians, 2006.
Passik SD, Schreiber J, Kirsh KL, Portenoy RK. A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management? Journal of Pain and Symptom Management, 2000, 19:40–4.
Caplan YH, Goldberger BA. Alternative specimens for workplace drug testing. Journal of Analytical Toxicology, 2001, 25:396–399.
Conigliaro C, Reyes CR, Schultz JS. Principles of screening and early intervention. In: Graham AW, Schultz TK, Mayo-Smith M, Ries RK, Wilford BB, eds. Principles of addiction medicine, third edition. Chevy Chase, MD: American Society of Addiction Medicine, 2003, 323–1
Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clinica Belgica, 2000, 55:323–333.
Cook JD, Caplan YH, LoDico CP, Bush DM. The characterization of human urine for specimen validity determination in workplace drug testing: a review. Journal of Analytical Toxicology, 2000, 24:579–588.
Casavant MJ. Urine drug screening in adolescents. Pediatric Clinics of North America, 2002, 49:317–327.
Huestis MA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC–MS. Journal of Analytical Toxicology, 1995, 19:443–44.
Simpson D, Braithwaite RA, Jarvie DR, et al. Screening for drugs of abuse (II): cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Annals of Clinical Biochemistry, 1997, 34:460–510.
Shults TF, St. Clair, S. The Medical Review Officer Handbook. 7th ed. Research Triangle Park NC. Quadrangle Research, 1999.
MROALERT November 6 Vol. XVII; No. 9(1–4)
American Academy of Pain Management, American Pain Society. The use of opioids for the treatment of chronic pain. Consensus Statement, 1996. www.ampainsoc.org.
Fishman SM, Bandman TB, Edwards A, et al. The opioid contract in the management of chronic pain. Journal of Pain and Symptom Management, 1999, 18:27–37.
Heit HA. Creating and Implementing Opioid Agreements. Disease Management Digest, 2003, 7(1):2–3, in: Care Management, 2003, 9
Passik SD, Heit HA, Kirsh KL. Reality and Responsibility: A Commentary on the Treatment of Pain and Suffering in a Drug-Using Society. Journa of Opioid Management, 2006, 2(3):1–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Heit, H.A., Lipman, A.G. (2009). Pain: Substance Abuse Issues in the Treatment of Pain. In: Biobehavioral Approaches to Pain. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78323-9_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-78323-9_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78322-2
Online ISBN: 978-0-387-78323-9
eBook Packages: MedicineMedicine (R0)